Research ArticleClinical Investigation
A Rapid and Safe Infusion Protocol for 177Lu Peptide Receptor Radionuclide Therapy
Sander C. Ebbers, Maarten W. Barentsz, Bart de Keizer, Gerard C. Krijger, Marnix G.E.H. Lam and Arthur J.A.T. Braat
Journal of Nuclear Medicine June 2021, 62 (6) 816-822; DOI: https://doi.org/10.2967/jnumed.120.252494
Sander C. Ebbers
1Department of Nuclear Medicine, University Medical Center Utrecht, Utrecht, The Netherlands; and
Maarten W. Barentsz
2Department of Radiology, University Medical Center Utrecht, Utrecht, The Netherlands
Bart de Keizer
1Department of Nuclear Medicine, University Medical Center Utrecht, Utrecht, The Netherlands; and
Gerard C. Krijger
1Department of Nuclear Medicine, University Medical Center Utrecht, Utrecht, The Netherlands; and
Marnix G.E.H. Lam
1Department of Nuclear Medicine, University Medical Center Utrecht, Utrecht, The Netherlands; and
Arthur J.A.T. Braat
1Department of Nuclear Medicine, University Medical Center Utrecht, Utrecht, The Netherlands; and
In this issue
Journal of Nuclear Medicine
Vol. 62, Issue 6
June 1, 2021
A Rapid and Safe Infusion Protocol for 177Lu Peptide Receptor Radionuclide Therapy
Sander C. Ebbers, Maarten W. Barentsz, Bart de Keizer, Gerard C. Krijger, Marnix G.E.H. Lam, Arthur J.A.T. Braat
Journal of Nuclear Medicine Jun 2021, 62 (6) 816-822; DOI: 10.2967/jnumed.120.252494